Cyril Philip is a Principal at Providence Ventures (PV), where he focuses on investments in healthcare technology, tech-enabled services, and digital health. Cyril joined Providence as one of the first hires of the newly formed venture team in 2015. He currently serves as a Board Observer at Wildflower Health and Binary Fountain. Cyril also served on the Board of precision medicine company N-of-One through its sale to Qiagen. Prior to joining PV, Cyril worked in Investment Banking at UBS and middle market private equity at Halyard Capital. Cyril graduated from the Tepper School of Business at Carnegie Mellon with a B.S. in Business Administration.